Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan / Ferrara, F.; Izzo, T.; Criscuolo, C.; Riccardi, C.; Muccioli, G.; Viola, A.; Pane, Fabrizio; Palmieri, S.. - In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. - ISSN 1083-8791. - ELETTRONICO. - 16:7(2010), pp. 1018-1024.

Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.

PANE, FABRIZIO;
2010

2010
Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan / Ferrara, F.; Izzo, T.; Criscuolo, C.; Riccardi, C.; Muccioli, G.; Viola, A.; Pane, Fabrizio; Palmieri, S.. - In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. - ISSN 1083-8791. - ELETTRONICO. - 16:7(2010), pp. 1018-1024.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/371596
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 8
social impact